FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

421777009: Abatacept (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2615083013 Abatacept (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2617723017 Abatacept en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49501000195112 abatacept it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
788511000172119 abatacept fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63661000195119 Abatacept de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abatacept (substance) Is a Fusion protein (substance) true Inferred relationship Some
Abatacept (substance) Is a agent antirhumatismal false Inferred relationship Some
Abatacept (substance) Is a Immunosuppressant (substance) true Inferred relationship Some
Abatacept (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing abatacept (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Abatacept (substance) Inferred relationship Some 1
Abatacept 250mg powder for injection solution 15mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abatacept (substance) Inferred relationship Some
Abatacept therapy (procedure) Direct substance True Abatacept (substance) Inferred relationship Some 2
Abatacept only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Abatacept (substance) Inferred relationship Some 1
Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Abatacept (substance) Inferred relationship Some 1
Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Abatacept (substance) Inferred relationship Some 1
Abatacept only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Abatacept (substance) Inferred relationship Some 1
Product containing abatacept in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Abatacept (substance) Inferred relationship Some 1
Product containing precisely abatacept 125 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Abatacept (substance) Inferred relationship Some 1
Product containing precisely abatacept 125 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Abatacept (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start